BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioNJ - ECPv6.17.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://bionj.org
X-WR-CALDESC:Events for BioNJ
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260929T090000
DTEND;TZID=America/New_York:20260929T163000
DTSTAMP:20260915T174257Z
CREATED:20260611T135047Z
LAST-MODIFIED:20260915T174257Z
UID:18278-1790672400-1790699400@bionj.org
SUMMARY:2026 BioNJ Manufacturing Summit
DESCRIPTION:Manufacturing the Future of Biopharma: Driving Innovation\, Resilience & Patient Impact\n\n\n\nTuesday\, September 29\, 2026 | 9:00 am – 4:30 pmCatalent\, 104 Campus Dr\, Princeton\, NJ 08540\n\n\n\nThank you for the tremendous interest in BioNJ’s Manufacturing Summit. At this time\, the event has reached capacity.To be added to the waitlist\, please contact Katie Grosselin at KGrosselin@BioNJ.org. Should space become available\, BioNJ will reach out directly. We look forward to welcoming all confirmed registrants on September 29. \n\n\n\n\nBecome a Sponsor\n\n\n\n\nBioNJ’s Manufacturing Summit brings together industry thought leaders to explore the trends\, challenges and opportunities shaping the future of biopharmaceutical manufacturing. Gain valuable insights on topics\, including the future of small and large molecule manufacturing\, supply chain resilience\, the evolving regulatory landscape and New Jersey’s continued investment and growth in manufacturing — plus much more. Explore the full agenda below. \n\n\n\nAs a special highlight\, attendees will also enjoy a guided tour of Catalent’s state-of-the-art manufacturing facility — offering a firsthand look at innovation in action. \n\n\n\n                \n                \n                            \n                            \n                    \n            \n    \n    \n    \n\n\n\n\n\n\n\n Speakers \n\n\n\n\n\n\n\n\n\n\n\nDavid BasileVice PresidentTechnical OperationsHovione \n\n\n\n\n\n\n\n\n\nMatthew BretonExecutive DirectorProcess Development &ManufacturingTr1X Bio \n\n\n\n\n\n\n\n\n\nJohn Coelho\, M.D. Senior Advisor\,Life SciencesNJEDA \n\n\n\n\n\n\n\n\n\nAnthony DeBiaseDirector\, Digital Process Development & Clinical ManufacturingContinua Process Systems \n\n\n\n\n\n\n\n\n\n\n\nGeorge EastwoodExecutive DirectorEmily Whitehead Foundation \n\n\n\n\n\n\n\n\n\nChristine Harman\, Ph.D.Lead Consumer Safety OfficerDivision of Manufacturing &Product Quality\, Office of Compliance & Biologics Quality\, Center of Biologics Evaluation & Research (CBER)Food & Drug Administration (FDA) \n\n\n\n\n\n\n\n\n\nDebbie HartPresident & CEOBioNJ \n\n\n\n\n\n\n\n\n\nPeter KellerCEOBlueWhale Bio \n\n\n\n\n\n\n\n\n\n\n\nBarbara LaveryChief Program OfficerAlliance for CancerGene Therapy \n\n\n\n\n\n\n\n\n\nMelanie MansbachGeneral ManagerCell TherapyCatalent Pharma Solutions \n\n\n\n\n\n\n\n\n\nLance MarquardtDirector\, Manufacturing OperationsProBio \n\n\n\n\n\n\n\n\n\nMichael MaurerGeneral ManagerVice President U.S. ManufacturingBeOne Medicines \n\n\n\n\n\n\n\n\n\n\n\nMiguel MontanoEnterprise Data Solutions ArchitectCatalent \n\n\n\n\n\n\n\n\n\nMichelle MoodyDirector\, Upstream Process DevelopmentThermo Fisher Scientific \n\n\n\n\n\n\n\n\n\nViet NguyenGlobal Chief Operating OfficerKashiv Biosciences \n\n\n\n\n\n\n\n\n\nHimanshu PatelExecutive DirectorSmall Molecule Manufacturing Science and TechnologyBristol Myers Squibb \n\n\n\n\n\n\n\n\n\n\n\nMariel RezendeAssociate PartnerMcKinsey & Company \n\n\n\n\n\n\n\n\n\nJennifer Spalding\, JDChief Commercial OfficerGeneral CounselCorporate SecretaryCivica Rx \n\n\n\n\n\n\n\n\n\nSanjay Srivasta\, Ph.D.Managing DirectorAccenture \n\n\n\n\n\n\n\n\n\nNorm StoffregenSenior Vice President & Site HeadEnzene Biosciences \n\n\n\n\n\n\n\n\n\n\n\nDan StrangeChief Technology OfficerCellular Origins \n\n\n\n\n\n\n\n\n\nLeAnn TimbleDirector\, Emerging Property Risk ControlAon \n\n\n\n\n\n\n\n\n\nJohn TomtishenGlobal Head\, Cell TherapyField Application Scientists &Strategic AlliancesCatalent Pharma Solutions \n\n\n\n\n\n\n\n\n\nBradley WattsPatient AdvocateCAR-T Recipient
URL:https://bionj.org/event/2026-bionj-manufacturing-summit/
LOCATION:Catalent\, 104 Campus Dr.\, Princeton\, New Jersey\, 08540\, United States
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2026/06/Manufacturing-Summit-Logo.png
END:VEVENT
END:VCALENDAR